Table 4.

Summary of Variables Included in Multivariate Models to Predict an Adverse Prognosis for COVID-19

VariableZhang, 2020 (J Clin Virol)Zhou, 2020 (PLOS One)Xu, 2020 (Theranostics)Liu, 2020 (J Clin Virol)Jang, 2020 (JKMS)Hou, 2020 (Infect Dis)Yu et al, 2020 (Theranostics)Wang, 2020 (Crit Care)Zhou, 2020 (Lancet)Liu, 2020 (Chin Med J)Liang, 2020 (JAMA Intern Med)Xie, 2020 (medRxIV)Yan, 2020 (medRxiv)Hu, 2020Luo, 2020 (Clin Infect Dis)Petrilli, 2020 (BMJ)Li, 2020Number of Models Including This Variable
Demographics
Age (increasing)xxxxxxxxxxx11
Male sexxx2
Vital signs
 Temperature (elevated)xxx3
 Oxygen saturation (decreased)xx2
Comorbidities
 Presence of comorbiditiesxxx3
 Diabetes mellitusxx2
 Tobacco usexx2
 History of cancerxx2
 Hypertensionx1
 Cardiovascular diseasex1
 Heart failurex1
 Chronic liver diseasex1
 Chronic kidney diseasex1
 Use of hypnoticx1
Symptoms
 Dyspneaxx2
 Coughx1
Hemoptysisx1
Loss of consciousnessx1
Laboratory results
 C-reactive protein (elevated)xxxxxxx7
 Lymphocyte count (decreased)xxxxxx6
 Lactate dehydrogenase (increased)xxxx4
 WBC count (increased)xx2
 Neutrophil count (increased)xx2
 Troponin (increased)xx2
 Procalcitonin (increased)xx2
 D-dimer (increased)xx2
 Interleukin-6 >32.1 pg/mLx1
 CK-MB (elevated)x1
 Albumin (decreased)x1
 Neutrophil/lymphocyte ratiox1
 Direct bilirubin (increased)x1
 Serum creatinine (increased)x1
  • WBC, white blood count; CK-MB, creatine kinase-MB.